Human immunodeficiency virus type 1 infection of human uterine epithelial cells: Viral shedding and cell contact-mediated infectivity

Journal of Infectious Diseases

Volumn 187, Issue 10, 2003, Pages 1522-1533

  Asin, Susana N ^a,b   Wildt Perinic, Dunja ^a   Mason, Sarah I ^b   Howell, Alexandra L ^a,b   Wira, Charles R ^a   Fanger, Michael W ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; VIRUS DNA; VIRUS RNA;

ARTICLE; CELL CONTACT; CONTROLLED STUDY; DNA TRANSCRIPTION; ENDOMETRIUM CELL; FEMALE GENITAL SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; T LYMPHOCYTE; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TRANSMISSION;

ANTIBODIES; ANTIGENS, CD4; CELL LINE; COCULTURE TECHNIQUES; EPITHELIAL CELLS; FEMALE; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; RECEPTORS, VIRUS; RNA, VIRAL; TRANSCRIPTION, GENETIC; UTERUS; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 0037907335     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/374782     Document Type: Article

References (50)

1. Burger H, Weiser B. Biology of HIV-1 in women and men. Obstet Gynecol Clin North Am 1997; 24:731-42.
2. Flaskerud JH, Ungvarski PJ. Overview and update of HIV disease. In: Ungvarski PJ, Flaskerud JH, eds. HIV/AIDS: a guide to primary care management. Philadelphia: WB Saunders, 1999:1-25.
3. Trujillo J, Goletiani N, Bosch I, et al. T-tropic sequence of the V3 loop is critical for HIV-1 infection of CXCR4-positive colonic HT-29 epithelial cells. J Acquir Immune Defic Syndr 2000; 25:1-10.
4. Bruggeman L, Ross M, Tanji N, et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 2000; 11:2079-87.
5. Jordan N, Kolios G, Abbot S, et al. Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J Clin Invest 1999; 104:1061-9.
6. Han Y, Ventura C, Black K, Cummins J Jr, Hall S, Jackson S. Productive human immunodeficiency virus-1 infection of epithelial cell lines of salivary gland origin. Oral Microbiol Immunol 2000; 15:82-8.
7. Fantini J, Cook DG, Nathanson N, Spitalnik SL, Gonzalez-Scarano F. Infection of colonic epithelial cell lines by type 1 human immunodefciency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci USA 1993; 90:2700-4.
8. Moses AV, Bloom FE, Pauza CD, Nelson JA. Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc Natl Acad Sci USA 1993; 90:10474-8.
9. Greenhead P, Hayes P, Watts P, Laing K, Griffin G, Shattock R. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 2000; 74:5577-86.
10. Dezzutti C, Guenthner P, Cummins J Jr, et al. Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J Infect Dis 2001; 183:1204-13.
11. Howell AL, Edkins RD, Rier SE, et al. Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract. J Virol 1997; 71:3498-506.
12. Tan X, Pearce-Pratt R, Phillips D. Productive infection of a cervical epithelial cell line with human immunodeficiency virus: implications for sexual transmission. J Virol 1993; 67:6447-52.
13. Furuta Y, Eriksson K, Svennerholm B, et al. Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc Natl Acad Sci USA 1994; 91:12559-63.
14. Alfsen A, Iniguez P, Bouguyon E, Bomsel M. Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1. J Immunol 2001; 166:6257-65.
15. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med 1997; 3:42-7.
16. Hocini H, Becquart P, Bouhlal H, et al. Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells. J Virol 2001; 75:5370-4.
17. Hocini H, Bomsel M. Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. J Infect Dis 1999; 179(Suppl 3):S448-53.
18. Hocini H, Becquart P, Bouhlal H, Adle-Biassette H, Kazatchkine MD, Belec L. Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers. Clin Diagn Lab Immunol 2000; 7:515-8.
19. Yeaman GR, Howell AL, Weldon S, et al. HIV receptor and co-receptor expression on human uterine epithelial cells: regulation during the menstrual cycle and implications for HIV infection. Immunology 2003; 108:1-10.
20. Marechal V, Clavel F, Heard JM, Schwartz O. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J Virol 1998; 72:2208-12.
21. Satyaswaroop G, Sivarajah A, Zaino RJ. Hormonal control of growth of human endometrial carcinoma in nude mouse model. In: Bresciani F, King RGB, Lippman ME, eds. Progress in cancer research and therapy. New York: Raven Press, 1988:430-5.
22. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986; 47:333-48.
23. Anderson CL, Guyre PM, Whitin JC, Ryan DH, Looney RJ, Fanger MW. Monoclonal antibodies to Fc receptors for IgG on human mononuclear phagocytes: antibody characterization and induction of superoxide production in a monocyte cell line. J Biol Chem 1986; 261:12856-64.
24. Lewis P, Hensel M, Emerman M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 1992; 11:3053-8.
25. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen ISY. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990; 61:213-22.
26. Iyengar S, Schwartz D, Clements J, Hildreth J. CD4-independent, CCR5-dependent simian immunodeficiency virus infection and chemotaxis of human cells. J Virol 2000; 74:6720-4.
27. Tateno M, Gonzalez-Scarano F, Levy J. Human immunodeficiency virus can infect CD4-negative human fibroblastoid cell lines. Proc Natl Acad Sci USA 1989; 86:4287-90.
28. Van't Wout A, Kootstra N, Mulder-Kampinga G, et al. Macrophage-tropic variants initiate human immunodeficiency virus type-1 infection after sexual, parenteral, and vertical transmission. J Clin Invest 1994; 94:2060-7.
29. - cell lines. AIDS 1991; 5:275-81.
30. Fantini J, Yahi N, Delezay O, Gonzalez-Scarano F. GalCer, CD26 and HIV infection of intestinal epithelial cells. AIDS 1994; 8:1347-8.
31. Morizono K, Harada S. Human immunodeficiency virus type 1 (HIV-1) infection and transcytosis activity of a HIV-1 susceptible clone from HeLa cell. Microbiol Immunol 1998; 42:313-20.
32. Phillips DM, Vanaja R, Xin T, Pearce-Pratt R. Mechanisms of sexual transmission of HIV: does HIV infect intact epithelia? Trends Microbiol 1994; 2:454-8.
33. Ulrich R, Schmidt W, Zippel T, Schneider T, Zeitz M, Riecken EO. Mucosal HIV infection. Pathobiology 1998; 66:145-50.
34. Smith PD, Li L, Meng G. Mucosal events in the pathogenesis of human immunodeficiency virus type 1 infection. J Infect Dis 1999; 179(Suppl 3):S436-40.
35. Mostad SB, Kreiss JK. Shedding of HIV-1 in the genital tract. AIDS 1996; 10:1305-15.
36. Melchers F, Rolink AG, Schaniel C. The role of chemokines in regulating cell migration during humoral immune responses. Cell 1999; 99:351-4.
37. McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest 1995; 96:456-64.
38. Shugars D, Sauls DL, Weinberg JB. Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type 1. Oral Dis 1997; 3:S70-2.
39. Shine NR, Wang SC, Konopka K, Burks EA, Duzgunes N, Whitman CP. Secretory leukocyte protease inhibitor: inhibition of human immunodeficiency virus-1 infection of monocytic THP-1 cells by a newly cloned protein. Bioorg Chem 2002; 30:249-63.
40. Zhang L, Yu W, He T, et al. Contribution of human α-defensin 1, 2 and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 2002; 298:995-1000.
41. Sharkey M, Teo I, Greenough T, et al. Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat Med 2000; 6:76-81.
42. Zhang LQ, MacKenzie P, Cleland A, Holmes EC, Leigh Brown AJ, Simmonds P. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol 1993; 67:3345-56.
43. + T cells. Science 1999; 286:1353-7.
44. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993; 261:1179-81.
45. Long EM, Martin HL, Kreiss JK, et al. Gender differences in HIV-1 diversity at time of infection. Nat Med 2000; 6:71-5.
46. Brogi A, Presentini R, Solazzo D, Piomboni P, Costantino-Ceccarini E. Interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with a galactoglycerolipid associated with human sperm. AIDS Res Hum Retroviruses 1996; 12:483-9.
47. Bhat S, Spitalnik SL, Gonzalez-Scarano F, Silberberg DH. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci USA 1991; 88:7131-4.
48. Gadella BM, Hammache D, Pieroni G, Colenbrander B, van Golde LM, Fantini J. Glycolipids as potential binding sites for HIV: topology in the sperm plasma membrane in relation to the regulation of membrane fusion. J Reprod Immunol 1998; 41:233-53.
49. Pasquali JL, Kieny MP, Kolbe H, Christmann D, Knapp AM. Immunogenicity and epitope mapping of a recombinant soluble gp160 of the human immunodeficiency type 1 envelope glycoprotein. AIDS Res Hum Retroviruses 1990; 6:1107-13.
50. Feil C, Augustin HG. Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. Biochem Biophys Res Commun 1998; 247:38-45.